Jump to content
RemedySpot.com

Question of ALT flare during switch to adefovir from lamivudine: A single center open-label, randomized, safety study (June 17, 2005 to February 5, 2009)

Rate this topic


Recommended Posts

Posted

J Med Virol. 2010 Sep;82(9):1489-93.

Question of ALT flare during switch to adefovir from lamivudine: A single center

open-label, randomized, safety study (June 17, 2005 to February 5, 2009).

Hann HW, Dunn SR, Ahn M, Park SY.

Liver Disease Prevention Center, Division of Gastroenterology and Hepatology,

Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

hie-won.hann@...

Abstract

Earlier clinical studies have reported an ALT flare greater than 10 times the

upper limit of normal in some patients with chronic hepatitis B when their

lamivudine (LAM) treatment was switched to adefovir (ADV) therapy. The current

study compared the safety of switching directly to ADV versus overlapping LAM

and ADV for 3 months followed by ADV monotherapy. Patients with chronic

hepatitis B receiving LAM therapy for > or = 6 months were eligible for the

study regardless of the presence of LAM resistance, HBeAg status or serum ALT

levels. Eighteen patients (13 males) were randomized to direct switch to ADV and

17 patients (10 males) to overlap. HBV-DNA, ALT, albumin, and total bilirubin

were assayed at baseline, 3, 6, 9, and 12 months. Study drugs were discontinued

at the end of 12 months with the follow up at 3 and 6 months. The decision to

continue antiviral therapy was made at the discretion of the investigator.

Baseline ALT levels were similar between the direct switch and overlap group:

median ALT (U/L) was 44.0 (16-266) and 33.0 (19-367) for direct switch for

overlap group, respectively (P = 0.42). No ALT flare was noted at 3 months in

either group: median ALT decreased from 44.0 to 34.5 U/L in the direct switch

group, and from 33.0 to 23.0 in the overlap group. Furthermore, no patient in

either group exhibited ALT flare throughout the 12 months. This study did not

show an ALT flare during switch to ADV at 3 months or at any time later.

PMID: 20648601 [PubMed - indexed for MEDLINE]

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...